[Translated article] The Utility of long-Term Number Needed to Treat to Evaluate Interleukin 17 and 23 Inhibitor Therapies in the Treatment of Moderate to Severe Plaque Psoriasis A. González-Domínguez; N. García-Agua; E. Dauden; P. Ventayol-Bosch;

Experiencia en la práctica clínica tras la optimización de la dosis del secukinumab en la psoriasis moderada-severa. Serie retrospectiva de 11 casos Á. Aguado Vázquez; F.J. Melgosa Ramos; C. Alonso Díez; A. Mateu Puchades;

[Translated article] Real-World Experience of Secukinumab Dose Optimization in Moderate-to-Severe Psoriasis. Retrospective, Single-Center Series of 11-Patients Á. Aguado Vázquez; F.J. Melgosa Ramos; C. Alonso Díez; A. Mateu Puchades;